Thailand national influenza programme: influenza factsheet 2020

Thailand Influenza Surveillance – Landscape Analysis 2020 Basic information (2020) Total population 66 558 9351 Children <5 years 3 185 7391 Under-5 mortality rate (per 1000 live births) 9.51 Life expectancy at birth (years) 77.72 Provinces/divisions/regions/zones 77 Districts 928 Total health expenditure (% of GDP) 3.71 Income level (World Bank) Upper middle3 1https://www.who.int/southeastasia/health-topics/immunization 2https://www.who.int/gho/publications/world_health_statistics/2020/en/ 3https://data.worldbank.org/ Influenza Like Illness (ILI) Surveillance Type of ILI surveillance Sentinel Sites involved in ILI sentinel surveillance Hospitals (outpatients) Surveillance case definition used for ILI case ascertainment WHO 2011 Is laboratory confirmation sought in ILI cases? Yes Number of ILI sentinel surveillance sites 32 Number of states/districts covered by the ILI sentinel surveillance system 20 % of the population covered by the ILI sentinel surveillance system 35% Denominator used for ILI surveillance Catchment population (of the sentinel surveillance site) Reporting frequency to the national level Weekly Type of data reported Analytical Reporting Form of the data reporting Electronic Severe Acute Respiratory Infection (SARI) Surveillance Type of SARI surveillance Sentinel Sites involved in SARI sentinel surveillance Hospitals (inpatients) Surveillance case definition used for SARI case ascertainment WHO 2011 Is laboratory confirmation sought in SARI cases? Yes Number of SARI sentinel surveillance sites 32 Number of states/districts covered by the SARI sentinel surveillance system 20 % of the population covered by the SARI sentinel surveillance system 35% Denominator used for SARI sentinel surveillance Catchment population ( of the sentinel site) Reporting frequency to the national level Weekly Type of data reported Analytical Reporting Form of the data reporting Electronic INFLUENZA FACTSHEET 2020 THAILAND National Influenza Programme Influenza Surveillance – Landscape Analysis 2020 Thailand Influenza- like illness (ILI) surveillance: The number and the proportion of ILI cases per 1000 outpatients, Jan 2018–Jan 2020 Source: GISRS/ FLUMART (http://apps.who.int/flumart/) Location of Influenza sentinel surveillance sites North region – Chiand Mai – Chiang Rai North-East region – Nakhon Ratchasima – Nong Khai – Udonthani – Nakhon Phanom – Yasothon – Maha Sarakham – Loei Central region – Bangkok – Ayutthaya – Lop Buri – Ratchaburi – Chanthaburi – Phetchaburi – Prachuap Khiri Khan South region – Nakhon Si Thammarat – Surat thani – Trang – Phuket Intensive Care Unit (ICU) surveillance Does the country have surveillance for influenza in the ICU? No Is laboratory confirmation sought in ICU cases? – Is case-based information collected? – Mortality surveillance Is timely all-cause mortality data (i.e. within one month) available in the country? Yes Thailand Influenza Surveillance – Landscape Analysis 2020 Virological surveillance system Does the country have virological surveillance? Yes Type of virological surveillance Sentinel – If sentinel, number of sites involved 32 Is epidemiological case information collected? Yes – If yes, are the laboratory results linked to epidemiological data? Yes The average number of virological samples processed per week 60 Are samples processed from ILI or SARI sentinel surveillance systems? Yes, from both systems Does the country have virus isolation capacity? Yes Does the country have RT-PCR capacity? Yes – % laboratories that perform RT-PCR No data (private sector) – % RT-PCR laboratories that report to NIC 0% Does the country use rapid diagnostic testing for influenza surveillance? No Does the country have sequencing capacity? Yes Does the country test for other respiratory viruses? Yes Virological surveillance: The number and percentage of specimens positive for influenza and subtypes, 2018–2020 National Influenza Centre Does the country have a National Influenza Centre (NIC) or national laboratory? Yes, NIC (established in 1972) Assays routinely performed at the NIC or national laboratory qRT-PCR, virus isolation, DNA sequencing Does the NIC have – Virus isolation capability – Antigenic characterisation capability – Antiviral susceptibility testing capability – Sequencing capability Yes Yes Yes Yes Does the NIC test for other respiratory viruses? Yes –Adenovirus, Parainfluenza virus 1–4, Human rhinoviruses (HRV), Respiratory syncytial virus (RSV) A-B, Human bocavirus (HBoV), Human metapneumovirus (HMPV), Human coronavirus (HCoV) HCoV 229E, HCoV NL63, HCoV OC43, hepatitis E virus (HEV) Does the country have a quality control plan? Yes Does the country follow national biosafety and biosecurity policy guidelines? Yes Influenza Surveillance – Landscape Analysis 2020 Thailand For technical information, please contact: Dr Pushpa Ranjan Wijesinghe, Programme Area Manager (Infectious Hazard Management). Email: wijesinghep@who.int Does the country forward samples to a WHO CC? Yes – US CDC, Atlanta, USA; Victorian Infectious Diseases Reference Laboratory (VIDRL) Melbourne, Australia – How often? Twice per year Reporting Frequency of national reports Weekly Are epidemiological and virological data integrated? Yes, both types of data integrated Reported via a website? Yes – www.thainihnic.org https://ddc.moph.go.th/doe/ Does the country report to FluID? – Year of beginning of reporting – Frequency of reporting Yes 2003 Weekly Does the country report to FluNet? – Year of beginning of reporting – Frequency of reporting Yes 2011 Weekly Are there fixed outbreak thresholds? Yes Level at which data are stored, managed and analysed National level Has formal training on data reporting and analysis been provided to surveillance and laboratory staff? – If yes, when? – Has a training session been planned? If yes, when? Yes Jan 2020 No Vaccination Does the country have a formal seasonal influenza vaccination policy? Yes Has seasonal influenza vaccine been introduced in the public sector? – Year introduced – Recommended risk groups – Vaccination period – Northern/Southern hemisphere vaccine? – Vaccine type Yes 2004 Pregnant; <2 years; ≥65 years; healthcare personnel; poultry cullers; chronic diseases; mental disability; obesity May-Sept Southern hemisphere vaccine Trivalent Influenza Vaccine (TIV) Is seasonal influenza offered in the private sector? – Only offered to particular risk groups? – Vaccination period – Northern/Southern hemisphere vaccine? – Vaccine type Yes No Available all year Southern Quadrivalent Is vaccine offered to Hajj and Umrah pilgrims? No Vaccine production capacity No Pandemic preparedness Does the country have a National Influenza Pandemic Preparedness Plan? – Year developed – Year last updated Yes 2005 2012 Has the country performed simulation exercises? Yes – table top Are there laboratory testing strategies in place for different phases of an influenza pandemic? – Are there surge capacity plans? – Does the pandemic preparedness plan include a detailed National Pandemic Vaccine Deployment Plan? – Are there priority groups? Yes Yes – pregnant women, children 6 months-2 years, persons ≥65 years, persons with chronic diseases, obese persons, mental disability